L
Loestrin
A $63.5 million settlement resolves claims that drug makers conspired to keep generic Loestrin birth control off the market.
ClosedUnited States-wideClaim status: Claim window closedPayout: Closed settlementNo longer claimable
About this settlement
Class members who purchased specific Loestrin birth control products may be eligible to claim compensation from this antitrust settlement.
This settlement resolves allegations that manufacturers conspired to delay generic versions of Loestrin birth control, affecting consumers who purchased certain brands.
Who qualifies
- Individuals who purchased certain Loestrin birth control products.
- Class members as defined by the settlement terms.
Closed settlement
Claim status: Claim window closed